Heron Therapeutics Financial Overview
Heron Therapeutics's market cap is currently $243.87M. The company's EPS TTM is $-0.1; its P/E ratio is ―; Heron Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
